Last reviewed · How we verify
NCT06881940: CARPTOX-BC
Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab
NA trial testing Rehabilitation Program in Cancer Therapy-Related Cardiac Dysfunction in 284 participants. Not yet recruiting.
1 December 2028
Quick facts
| Lead sponsor | Instituto Nacional de Cardiologia Ignacio Chavez |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 284 |
| Start date | 1 April 2025 |
| Primary completion | 1 December 2028 |
| Estimated completion | 1 December 2029 |
| Sites | 2 locations across Mexico |
Drugs / interventions tested
- Rehabilitation Program
- No Rehabilitation Program
Conditions studied
- Cancer Therapy-Related Cardiac Dysfunction — all drugs for Cancer Therapy-Related Cardiac Dysfunction →
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez — full company profile →
Who can join
Adults 18 to 70, female only, with Cancer Therapy-Related Cardiac Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of a cardiac rehabilitation protocol, incorporating aerobic and resistance exercise, in reducing the incidence of cardiotoxicity in breast cancer patients receiving treatment with anthracyclines and/or trastuzumab through a randomized, active control group, open-label clinical trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06881940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Rehabilitation Program
Trials testing the same drug.
- NCT06965894 — Lower Extremity Pressure Splints in HP · NA · recruiting
- NCT04319250 — The Effectiveness Of Ischemic Compression And IASTM In Trigger Point Treatment In Patients With Rotator Cuff Tear · NA · completed
- NCT04228068 — The Stronger at Home Study · NA · completed
Other recruiting trials for Cancer Therapy-Related Cardiac Dysfunction
Currently open trials in the same condition.
- NCT05732051 — Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients · Phase 2 · recruiting
Other Instituto Nacional de Cardiologia Ignacio Chavez trials
Trials by the same sponsor.
- NCT06342141 — Empagliflozin for No-reflow Phenomenon in PCI for STEMI · Phase 2 · active not recruiting
- NCT06521307 — Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery · NA · not yet recruiting
- NCT06584734 — Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients · NA · active not recruiting
- NCT06013813 — Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI · NA · unknown
- NCT05580510 — " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06881940 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Nacional de Cardiologia Ignacio Chavez
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06881940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing